1.
New theory addresses frozen Earth paradox
WASHINGTON, Oct. 13 (UPI) -- The U.S. Food and Drug Administration has approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia.
"Benign prostatic hyperplasia (also known as an enlarged prostate gland) can seriously impact the quality of life of men as they age," said George Benson, deputy director of the FDA's division of reproductive and urological products. "This product will provide another treatment option for men suffering symptoms of an enlarged prostate."
The drug will be available in a once-daily capsule, the FDA said, noting Rapaflo is not recommended for men with severe kidney (renal) or liver (hepatic) impairment and is not approved for pediatric use.
Rapaflo is manufactured by Watson Pharmaceuticals Inc. of Corona, Calif., and will be distributed by Watson Pharma Inc. under license from Kissei Pharmaceutical Co. Ltd. of Nagano, Japan.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
NEW YORK, May 31 (UPI) --
Actor Michael McKean, who was hit by a car last week while walking in New York, says he has been discharged from St. Luke's Hospital.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption
